Abiopharma

New Form 4/A - ClearSign Technologies Corp <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0001104659-26-049608 <b>Size:</b> 7 KB

📋 MPM Asset Management LLC (Shareholder) plans to sell 21K shares of Werewolf Therapeutics, Inc. (at $0.81 each, total $17K) Filed: Apr 27, 2026 | ID: 027603

📋 MPM Asset Management Investors BV2014 LLC (Shareholder) plans to sell 4K shares of Werewolf Therapeutics, Inc. (at $0.81 each, total $4K) Filed: Apr 27, 2026 | ID: 027601

Molloie William H. Jr. 🟢 acquired 2.0K shares of Silvaco Group, Inc. (SVCO) Transaction Date: Apr 22, 2026 | Filing ID: 027599

📋 MPM BioVentures 2014 (B), L.P. (Shareholder) plans to sell 9K shares of Werewolf Therapeutics, Inc. (at $0.81 each, total $7K) Filed: Apr 27, 2026 | ID: 027598

(10% Negative) LIGHTBRIDGE CORP (LTBR) Reports Q2 2026 Financial Results

📋 UBS Oncology Impact Fund, L.P. (Shareholder) plans to sell 108K shares of Werewolf Therapeutics, Inc. (at $0.81 each, total $88K) Filed: Apr 27, 2026 | ID: 027597

(99% Neutral) GULF RESOURCES, INC. (GURE) Files Form 8-K

(99% Neutral) FLY-E GROUP, INC. (FLYE) Announces Update on Collaboration with IRS Employer Identification Number

(99% Neutral) KEEN VISION ACQUISITION CORP. (KVAC) Announces Business Combination